Sign in

CIK 0000318154 · Large accelerated filer

Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
953540776
Phone
(805)447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. DEFA14A Proxy Proxy Materials
  2. DEFA14A Proxy Proxy Materials
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. ARS Other Annual Report to Security Holders
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Shares withheld for taxes EVP, Operations gave up 5,621 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP & Chief Technology Officer gave up 6,022 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP, Human Resources gave up 1,616 shares (to pay taxes)
  10. 4 Shares withheld for taxes SVP, Business Development gave up 707 shares (to pay taxes)
  11. 4 Shares withheld for taxes SVP & CCO gave up 787 shares (to pay taxes)
  12. 4 Shares withheld for taxes EVP & CFO gave up 5,748 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP & Gen. Counsel & Sec. gave up 5,353 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Global Commercial Ops gave up 6,691 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chairman, CEO and President gave up 21,294 shares (to pay taxes)
  16. 4 Shares withheld for taxes VP, Finance & CAO gave up 327 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chairman, CEO and President gave up 84,285 shares (to pay taxes)
  18. 4 Grant or award EVP, Operations acquired 11,259 shares (grant or award)
  19. 4 Grant or award EVP & Chief Technology Officer acquired 12,063 shares (grant or award)
  20. 4 Grant or award SVP, Human Resources acquired 3,484 shares (grant or award)

Page 5 of 161 · 3,201 filings